Jay Amsterdam’s comment on Charles Beasley’s response to Barry Blackwell’s reply to his comment
Charles Beasley’s comment on Barry Blackwell’s Corporate Corruption in the Psychopharmaceutical Industry

Your recent INHN essay is, in my estimation, an excellent disposition on a highly complex and contentious topic. Job well done. Thank you so much for providing the well described examples of sample sizes required for identifying ‘hypothetical’ adverse events in the course of new drug development. Thanks also for providing your easily understandable explanations on this thorny issue. I think that I’ll read it a second time!

April 19, 2018